Spectrum

The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic

Retrieved on: 
Tuesday, March 26, 2024
Diagnosis, Depression, Sleep, The9, Synthetic media, Annual report, Myenteric plexus, Agreement, Disease, Alzheimer's disease, Central nervous system, Attention deficit, Bipolar disorder, Anxiety, AI, IPO, Insurance, Sympathetic nervous system, LLM, Drug development, WM, Spectrum, Good, Generative, Pharmaceutical industry

SHANGHAI, March 26, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that it signed a definitive share purchase agreement (the "Agreement") with WM Therapeutic Co., Ltd. ("WM Therapeutic"), a company operating Generative AI (GenAI) large language model (LLM) multi-dimensional and multi-omics digital precision medicine platform for brain disease, to purchase an additional 21.7% shares of WM Therapeutic by cash and issuance of The9's restricted shares.

Key Points: 
  • SHANGHAI, March 26, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that it signed a definitive share purchase agreement (the "Agreement") with WM Therapeutic Co., Ltd. ("WM Therapeutic"), a company operating Generative AI (GenAI) large language model (LLM) multi-dimensional and multi-omics digital precision medicine platform for brain disease, to purchase an additional 21.7% shares of WM Therapeutic by cash and issuance of The9's restricted shares.
  • With the signing of this Agreement, The9 will own 30% of WM Therapeutic.
  • The9 is also granted a purchase option to purchase up to 51% of the total shares of WM Therapeutic under certain conditions.
  • WM Therapeutic develops GenAI large language model brain disease screening platform and digital human personalized psychological consultant, AI precision diagnostic equipment, personalized neuromodulation treatment equipment, Generative AI large language model and AI drug clinical research platform.

THE AUTISM SOCIETY OF AMERICA HITS THE ROAD FOR AUTISM ACCEPTANCE MONTH WITH THE 'ROAD TO ACCEPTANCE' PROJECT

Retrieved on: 
Monday, March 25, 2024
Pura, Chrysler Pacifica, Health, IHeartMedia, Friends, Clear Channel Outdoor, Employment, Sound, Caregiver, Partnership, 39/Smooth, Autism Society of America, City, Road, Safety, Spectrum, Skullcandy, Vaccine

ROCKVILLE, Md., March 25, 2024 /PRNewswire/ -- Today, the Autism Society of America, the nation's largest and oldest grassroots Autism organization, announced the 'Road to Acceptance' project. As a part of its larger Autism Acceptance Month campaign, the project showcases the unique experiences within the Autism community, driving inclusion and equity in employment, health, and safety for the Autism community.

Key Points: 
  • ROCKVILLE, Md., March 25, 2024 /PRNewswire/ -- Today, the Autism Society of America, the nation's largest and oldest grassroots Autism organization, announced the 'Road to Acceptance' project.
  • As a part of its larger Autism Acceptance Month campaign, the project showcases the unique experiences within the Autism community, driving inclusion and equity in employment, health, and safety for the Autism community.
  • "Autism Acceptance Month provides the opportunity to demonstrate the diversity of experiences and support needs across the Autism community," says Kristyn Roth, Chief Marketing Officer for the Autism Society of America.
  • For more information on the Road to Acceptance project and road stop locations and dates, please visit RoadToAcceptance.org.

Sheppard Pratt Announces Kathy Flannery, MEd, as Vice President and Chief of Schools

Retrieved on: 
Monday, March 25, 2024
Towson University, Intellectual, Applied behavior analysis, Cornell University, School, Disability studies, Autism spectrum, MD, Student, MBA, Curriculum, Master of Education, Pennsylvania State University, National Association, Spectrum

BALTIMORE, March 25, 2024 /PRNewswire/ -- Sheppard Pratt is pleased to announce that Kathy Flannery, MEd, has been promoted to the role of vice president and chief of schools.

Key Points: 
  • BALTIMORE, March 25, 2024 /PRNewswire/ -- Sheppard Pratt is pleased to announce that Kathy Flannery, MEd, has been promoted to the role of vice president and chief of schools.
  • Sheppard Pratt operates 11 nonpublic special education schools across the state of Maryland, serving students with autism, emotional disabilities, and intellectual disabilities.
  • As vice president and chief of schools, Flannery will provide leadership, oversight, and direction for the management of Sheppard Pratt Schools.
  • "The success of Sheppard Pratt Schools is made possible by outstanding educators, support staff, and leaders like Kathy," says Harsh K. Trivedi, MD, MBA, president and CEO of Sheppard Pratt.

D2L Expands Footprint in Non-profit Sector

Retrieved on: 
Monday, March 25, 2024
CIO, Organization, Bongo, Learning, LCS, GWI, Education, The Robb Nash Project, Quaternary, Curriculum, Spectrum, Parent, Canadian Mental Health Association, Nursing

"D2L is proud to support non-profit organizations dedicated to fostering positive change in our world through the transformative force of education" said Bill Sheehan, Global Head of Associations Strategy at D2L.

Key Points: 
  • "D2L is proud to support non-profit organizations dedicated to fostering positive change in our world through the transformative force of education" said Bill Sheehan, Global Head of Associations Strategy at D2L.
  • D2L also attended and sponsored the National Mentoring Summit, convened by MENTOR, in January 2024.
  • With a focus on accessibility, D2L aims to support an educational experience tailored to the diverse needs of Autism Ontario's stakeholders.
  • "Year Up is delighted to work with D2L," said Gary Flowers, CIO, Transformative and Technology Services at Year Up.

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK

Retrieved on: 
Monday, March 25, 2024
Suicide, Depression, Conference, HOPE, Science, NMDA, Patient, CNS, Efficacy, Therapy, Risk, Neurotoxicity, Spectrum, PTSD, Pharmaceutical industry

RADNOR, Pa., March 25, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx Pharmaceuticals and co-CEO of HOPE Therapeutics, will present at the Ketamine 2024 Conference, which is planned for March 25-27, 2024, at the Blavatnik School of Government in Oxford, UK.

Key Points: 
  • RADNOR, Pa., March 25, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx Pharmaceuticals and co-CEO of HOPE Therapeutics, will present at the Ketamine 2024 Conference, which is planned for March 25-27, 2024, at the Blavatnik School of Government in Oxford, UK.
  • The Ketamine 2024 Conference assembles many of the top scientists and clinicians in the field from around the world and is a forum for top researchers and experienced and interested clinicians to learn from each other about the therapeutic use of Ketamine and related compounds for affective disorders.
  • Dr. Javitt will present a keynote talk titled, "Ketamine: the Efficacy is Clear, Approval is Critical, and the Risks Must be Balanced."
  • "HOPE Therapeutics builds upon four decades of scientific discovery related to the role of the brain's NMDA receptor and the effects of ketamine and other NMDA-antagonist drugs in rapidly attenuating symptoms of depression and suicidality.

Acetic Acid Market Projected to Reach $12.33 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, March 22, 2024
Health, Taste, BP, Textile, Growth, Longevity, Acetic acid, SABIC, Process engineering, Vegetable, Intelligence, Polymer, INEOS, Celanese, Food quality, Edible, Food preservation, MAP, Concentration, Concentrated, Investment, Water, Safety, Crystallization, Spectrum, Food safety, Table

The acetic acid market has flourished in the Americas and is driven by its demand across the packaging, textiles, and food sectors, with significant advancements toward sustainable practices.

Key Points: 
  • The acetic acid market has flourished in the Americas and is driven by its demand across the packaging, textiles, and food sectors, with significant advancements toward sustainable practices.
  • These dynamics highlight the global acetic acid market's resilience and potential for future growth amidst evolving environmental and technological landscapes.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Acetic Acid Market.
  • "Dive into the Acetic Acid Market Landscape: Explore 192 Pages of Insights, 572 Tables, and 26 Figures"

Acetic Acid Market Projected to Reach $12.33 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, March 22, 2024
Health, Taste, BP, Textile, Growth, Longevity, Acetic acid, SABIC, Process engineering, Vegetable, Intelligence, Polymer, INEOS, Celanese, Food quality, Edible, Food preservation, MAP, Concentration, Concentrated, Investment, Water, Safety, Crystallization, Spectrum, Food safety, Table

The acetic acid market has flourished in the Americas and is driven by its demand across the packaging, textiles, and food sectors, with significant advancements toward sustainable practices.

Key Points: 
  • The acetic acid market has flourished in the Americas and is driven by its demand across the packaging, textiles, and food sectors, with significant advancements toward sustainable practices.
  • These dynamics highlight the global acetic acid market's resilience and potential for future growth amidst evolving environmental and technological landscapes.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Acetic Acid Market.
  • "Dive into the Acetic Acid Market Landscape: Explore 192 Pages of Insights, 572 Tables, and 26 Figures"

Medal of Honor Recipients Recognize Americans for Valor and Values

Retrieved on: 
Thursday, March 21, 2024
Personality, Congress, Veteran, Medal of Honor, Autism spectrum, Coast guard, Teaching, CPR, Fire, Medal, Disability, Spectrum, Courage

The Congressional Medal of Honor Society —the Congressionally-chartered organization of the 63 living Medal of Honor Recipients—will hold its annual Citizen Honors Awards in Fort Belvoir, Virginia, to recognize five U.S. citizens and one nonprofit organization for demonstrating Medal of Honor Values in 2023--courage, sacrifice, citizenship, integrity, commitment, and patriotism. The program is one of the ways the Congressional Medal of Honor Society conducts its mission to promote values and honor.

Key Points: 
  • WASHINGTON, March 21, 2024 /PRNewswire/ -- Medal of Honor Recipients are spotlighting others on the day that Congress set aside to "foster public appreciation and recognition of Medal of Honor recipients"—National Medal of Honor Day, March 25, 2024.
  • The Congressional Medal of Honor Society —the Congressionally-chartered organization of the 63 living Medal of Honor Recipients—will hold its annual Citizen Honors Awards in Fort Belvoir, Virginia, to recognize five U.S. citizens and one nonprofit organization for demonstrating Medal of Honor Values in 2023--courage, sacrifice, citizenship, integrity, commitment, and patriotism.
  • The program is one of the ways the Congressional Medal of Honor Society conducts its mission to promote values and honor.
  • Medal of Honor Recipient and Society President Britt Slabinski commented, "Medal of Honor recipients know that there are many Americans who share the values we seek to promote through our outreach, and we think it is important to hold them up as role models for others.

Alan Kirshner, former Chairman and CEO of Markel Group, passes away

Retrieved on: 
Tuesday, March 19, 2024
Partnership, Kirshner, Humour, Life, Student, Spectrum, Future, Markel Corporation, MKL, Management

RICHMOND, Va., March 19, 2024 /PRNewswire/ -- Alan Kirshner, 88, former Chairman of the Board and Chief Executive Officer (CEO) of Markel Group Inc. (NYSE: MKL), passed away on March 17, 2024.

Key Points: 
  • RICHMOND, Va., March 19, 2024 /PRNewswire/ -- Alan Kirshner, 88, former Chairman of the Board and Chief Executive Officer (CEO) of Markel Group Inc. (NYSE: MKL), passed away on March 17, 2024.
  • He joined the Board of Directors in 1978 and became Chairman and CEO in 1986, the same year Markel became a public company.
  • Kirshner served as CEO through 2015, became Executive Chairman in 2016, and then became Chairman Emeritus in 2020.
  • Chairman of the Board Steve Markel added, "I worked side-by-side with Alan for nearly five decades.

Alan Kirshner, former Chairman and CEO of Markel Group, passes away

Retrieved on: 
Tuesday, March 19, 2024
Partnership, Kirshner, Humour, Life, Student, Spectrum, Future, Markel Corporation, MKL, Management

RICHMOND, Va., March 19, 2024 /PRNewswire/ -- Alan Kirshner, 88, former Chairman of the Board and Chief Executive Officer (CEO) of Markel Group Inc. (NYSE: MKL), passed away on March 17, 2024.

Key Points: 
  • RICHMOND, Va., March 19, 2024 /PRNewswire/ -- Alan Kirshner, 88, former Chairman of the Board and Chief Executive Officer (CEO) of Markel Group Inc. (NYSE: MKL), passed away on March 17, 2024.
  • He joined the Board of Directors in 1978 and became Chairman and CEO in 1986, the same year Markel became a public company.
  • Kirshner served as CEO through 2015, became Executive Chairman in 2016, and then became Chairman Emeritus in 2020.
  • Chairman of the Board Steve Markel added, "I worked side-by-side with Alan for nearly five decades.